Lupin is releasing Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, which are the generic of Boehringer ...

Thus, we showed that ipratropium bromide may be associated with a mechanism for cardiovascular-related deaths. These results are also consistent with results from other recent studies.

Active ingredients of dual-action Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol now delivered by new propellant-free inhaler RIDGEFIELD, Conn., Oct. 10, 2011 ...

Ipratropium bromide and albuterol are 2 different medicines. They have the same action. They relax the air passages and make breathing easier (bronchodilators).

Ipratropium bromide nasal solution (nasal spray), 0.03% and 0.06% are bioequivalent to Atrovent nasal spray, 0.03% and 0.06%, of Boehringer Ingelheim Pharmaceuticals, Inc. Ipratropium bromide nasal ...

Ipratropium bromide may increase risk for cardiovascular events. ScienceDaily . Retrieved June 3, 2025 from www.sciencedaily.com / releases / 2010 / 01 / 100105183800.htm ...

Boehringer Ingelheim announced a voluntary recall of over 350,000 Combivent Respimat (ipratropium bromide, albuterol) 20mcg/100mcg inhalation sprays due to a defective delivery system.

Objectives: To compare the efficacy and tolerability of formoterol (12 or 24µg twice daily) alone with combined ipratropium bromide and fenoterol in the treatment of chronic obstructive pulmonary ...

The FDA has advised consumers not to use albuterol sulfate inhalation solution, 0.083%, and ipratropium bromide inhalation solutions, 0.02%, unit-dose vials, purchased after September 8, 2009 and ...

Ipratropium bromide is used in bronchial asthma and in chronic obstructive pulmonary disease (COPD- a group of diseases that affect the lungs and airways). Ipratropium provides symptomatic relief ...